Plasma Phospholipid Transfer Protein Activity Is Decreased in Type 2 Diabetes During Treatment With Atorvastatin: A Role for Apolipoprotein E?
Dallinga-Thie, G. M., van Tol, A., Hattori, H., Rensen, P. C.N., Sijbrands, E. J.G.Volume:
55
Language:
english
Journal:
Diabetes
DOI:
10.2337/db05-1685
Date:
May, 2006
File:
PDF, 88 KB
english, 2006